A randomized controlled study for conbercept combined with macular micro-pulse laser photocoagulation for PCV treatment

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022071

Enrollment

Unknown

Registered

2019-03-23

Start date

2019-03-13

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polypoidal choroidal vasculopathy

Interventions

combined treatment group:macular micropulsed laser photocoagulation/conbercept

simple treatment group:conbercept

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients first diagnosed as polypoidal choroidal vasculopathy.

Exclusion criteria

Exclusion criteria: Concomitant with other ocular lesions; General condition is worse.

Design outcomes

Primary

Measure	Time frame
injection times per year;	—

Countries

China

Contacts

Public ContactLiying Hu

bluesky.0123@163.com+86 13602005806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026